Martin Widschwendter

Martin Widschwendter is a Professor of Women’s Cancer at the University of Innsbruck, Austria, and University College London, UK. He serves as a Visiting Professor at Karolinska Institutet’s Department of Women’s and Children’s Health, Division for Neonatology, Obstetrics, Gynaecology, and Reproductive Health, affiliated with Kristina Gemzell Danielsson’s research group.

• Research Focus: Mechanisms of women’s cancers (BRCA1 gene, progesterone dynamics), epigenetic risk assessment, prevention with antiprogestins, and early diagnosis via tumor DNA detection in blood.
• Collaborations: Joakim Dillner (Karolinska Institutet), Kristina Gemzell Danielsson (Karolinska Institutet), and international teams.
• Key Techniques: DNA methylation analysis, liquid biopsy, WID-qEC/WID-CIN tests for cancer detection.

Recent Publication Trends: His work emphasizes epigenetic biomarkers for early cancer detection (breast, ovarian, cervical, uterine), cross-population validation, and environmental factors like smoking in carcinogenesis. Collaborative studies span global health (Ghana trials), immunology (NK cell dysfunction), and technical innovations (HPLC-MS/MS for drug quantification).

Labs & Teams: Collaborates with Kristina Gemzell Danielsson’s research group at Karolinska Institutet and international consortia including ovarian tumor tissue analysts.